Organoid and organ-on-a-chip technologies represent a transformative leap in the field of biomedical science. Historically, traditional in vitro methods ...

The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

Despite groundbreaking advances in pediatric cancer research, many promising therapies never reach the children who need them most. Catherine Bollard, MD, is senior vice president and chief research ...

Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.

Just as species adapt over generations, our body's cells accumulate DNA changes throughout life. Most are harmless, yet a few "driver" mutations give a cell a competitive edge and can spark cancer.

Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) were trading at $30.25, down $5.60, or 15%, on word of the delay of data from the phase III X-tole2 trial with azetukalner in focal onset seizures ...

Organoids Market is Segmented by Type (Stem Cell Source, Tumor Cell Source), by Application (Biopharmaceutical Companies, ...

A joint research team affiliated with UNIST has developed a 3D-printed artificial tumor tissue capable of replicating the in ...

Abstract Heterogeneity and the absence of a tumor microenvironment (TME) in traditional patient-derived organoid (PDO) cultures limit their ...

As the Trump administration continues to make significant cuts to NIH budgets and personnel and to freeze billions of dollars ...